Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM)
PaperCitations, authors & open-access status
HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 88 citations, 2010 year and closed oa status.
88
Citations
2010
Year
closed
OA Status